Centessa Pharmaceuticals PLC (CNTA)
9.36
-0.11
(-1.16%)
USD |
NASDAQ |
May 06, 14:21
Centessa Pharmaceuticals Price to Book Value: 4.402 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 4.454 |
| May 02, 2024 | 4.492 |
| May 01, 2024 | 4.459 |
| April 30, 2024 | 4.308 |
| April 29, 2024 | 4.370 |
| April 26, 2024 | 4.196 |
| April 25, 2024 | 3.792 |
| April 24, 2024 | 4.017 |
| April 23, 2024 | 3.991 |
| April 22, 2024 | 4.246 |
| April 19, 2024 | 4.488 |
| April 18, 2024 | 4.471 |
| April 17, 2024 | 4.577 |
| April 16, 2024 | 4.683 |
| April 15, 2024 | 4.577 |
| April 12, 2024 | 4.806 |
| April 11, 2024 | 5.040 |
| April 10, 2024 | 4.734 |
| April 09, 2024 | 4.800 |
| April 08, 2024 | 4.564 |
| April 05, 2024 | 4.564 |
| April 04, 2024 | 4.403 |
| April 03, 2024 | 4.594 |
| April 02, 2024 | 4.811 |
| April 01, 2024 | 4.704 |
| Date | Value |
|---|---|
| March 28, 2024 | 4.798 |
| March 27, 2024 | 4.713 |
| March 26, 2024 | 4.568 |
| March 25, 2024 | 4.887 |
| March 22, 2024 | 5.180 |
| March 21, 2024 | 5.129 |
| March 20, 2024 | 5.027 |
| March 19, 2024 | 4.743 |
| March 18, 2024 | 4.440 |
| March 15, 2024 | 4.495 |
| March 14, 2024 | 4.378 |
| March 13, 2024 | 4.536 |
| March 12, 2024 | 4.541 |
| March 11, 2024 | 4.076 |
| March 08, 2024 | 4.612 |
| March 07, 2024 | 4.624 |
| March 06, 2024 | 4.612 |
| March 05, 2024 | 4.553 |
| March 04, 2024 | 4.670 |
| March 01, 2024 | 4.545 |
| February 29, 2024 | 4.394 |
| February 28, 2024 | 4.365 |
| February 27, 2024 | 4.750 |
| February 26, 2024 | 4.720 |
| February 23, 2024 | 4.603 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6228
Minimum
Jun 06 2022
74.92
Maximum
Jun 17 2021
4.045
Average
1.892
Median
Nov 29 2021
Price to Book Value Benchmarks
| TC BioPharm (Holdings) PLC | 1.513 |
| Adaptimmune Therapeutics PLC | 7.090 |
| Biodexa Pharmaceuticals Plc | 0.8094 |
| Verona Pharma PLC | 4.818 |
| NuCana PLC | 0.4371 |
Price to Book Value Related Metrics
| Price | 9.36 |
| Earnings Yield | -16.67% |
| Market Cap | 1.040B |